|1.||Herndon, David N: 12 articles (06/2015 - 06/2003)|
|2.||Wit, Jan M: 9 articles (06/2015 - 03/2010)|
|3.||Sas, Theo C J: 8 articles (10/2014 - 03/2010)|
|4.||Menke, Leonie A: 8 articles (10/2014 - 03/2010)|
|5.||de Muinck Keizer-Schrama, Sabine M P F: 7 articles (10/2014 - 03/2010)|
|6.||Otten, Barto J: 7 articles (10/2014 - 03/2010)|
|7.||Suman, Oscar E: 6 articles (06/2015 - 09/2005)|
|8.||Zandwijken, Gladys R J: 6 articles (01/2013 - 03/2010)|
|9.||Chinkes, David L: 5 articles (05/2011 - 06/2003)|
|10.||Jeschke, Marc G: 5 articles (05/2011 - 09/2005)|
|1.||Turner Syndrome (Turner's Syndrome)
01/01/2015 - "Eligible trials were identified by a literature search using the terms: Turner syndrome, oxandrolone. "
01/01/2011 - "Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial."
03/01/2015 - "Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social-emotional functioning in young adults with Turner syndrome."
10/01/2014 - "To evaluate karyotype-specific ear and hearing problems in young-adult patients with Turner syndrome (TS) and assess the effects of previous treatment with oxandrolone (Ox). "
10/01/2014 - "Karyotype-specific ear and hearing problems in young adults with Turner syndrome and the effect of oxandrolone treatment."
08/01/2004 - "LBM was significantly greater with oxandrolone at 6, 9, and 12 months after the burn (P < .001) and BMC at 12 months (P < .016). "
08/01/2007 - "Oxandrolone is safe and effective in promoting anabolism in large burns. "
09/01/2005 - "To study the efficacy of oxandrolone in severely burned children for 12 months after burn and 12 months after the drug was discontinued. "
05/01/2007 - "Oxandrolone has been shown to improve lean muscle mass in patients with burns. "
05/01/2011 - "In the current study, we evaluated whether oxandrolone treatment affects mechanisms of protein turnover in skeletal muscle and whole-body protein breakdown in pediatric burn patients 6 months postinjury. "
09/01/1991 - "We conclude that the addition of nutritional supplementation and oxandrolone to standard therapy of moderately severe or severe alcoholic hepatitis is well tolerated, and leads to more rapid improvement in the laboratory parameters measured."
11/01/1993 - "A cohort of 273 male patients enrolled in a Department of Veterans Affairs Cooperative Study performed to evaluate the efficacy of oxandrolone in combination with nutritional supplementation in moderate or severe alcoholic hepatitis. "
04/01/1993 - "A Veterans Affairs cooperative study involving 273 male patients was performed to evaluate efficacy of oxandrolone in combination with an enteral food supplement in severe alcoholic hepatitis. "
07/01/1995 - "Active nutrition therapy and the anabolic steroid oxandrolone (OX), in selected patients with severe alcoholic hepatitis, significantly improved liver status and survival. "
04/01/1993 - "A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study."
|4.||Body Weight (Weight, Body)
02/01/2009 - "In clinical studies, oxandrolone 10 mg orally twice/day improved wound healing, restored lean body mass, and accelerated body weight gain. "
02/01/2009 - "During the rehabilitation period, oxandrolone therapy with adequate nutrition and exercise improved lean body mass, increased muscle strength, and restored body weight. "
03/01/2006 - "Body weight increased in all groups, including the group receiving placebo, during the double-blind phase (1.1 +/- 2.7, 1.8 +/- 3.9, 2.8 +/- 3.3, and 2.3 +/- 2.9 kg in placebo and 20-, 40-, and 80-mg oxandrolone groups, respectively; all P < 0.014 vs. baseline). "
12/01/2003 - "We found that the body weight and lean mass which was restored during RH, was maintained 6 months after discontinuation of oxandrolone. "
06/01/2003 - "Body weights and fat free mass significantly decreased in the placebo group, while no changes were found in the oxandrolone-treated subjects. "
07/01/1997 - "We found that the average weight gain during the first 3 weeks was 14.5 +/- 2.5 pounds and that the physical therapy index was 8.8 +/- 0.5 of recovery in the oxandrolone-protein group (n = 7); both of these values were significantly greater than the corresponding values in the other groups. "
09/01/2008 - "Oral oxandrolone 0.1 mg/kg twice daily increased protein synthesis, lean body mass accretion, and muscle strength; improved serum visceral protein concentrations; promoted weight gain; and increased bone mineral content. "
01/01/2009 - "Larger studies are needed to determine if oxandrolone is an effective, safe, and affordable option to stimulate appetite, improve weight gain, and promote linear growth in patients with CF."
03/01/1999 - "Oxandrolone, an anabolic steroid, is used in promoting weight gain and, most important lean body mass (LBM), in patients with HIV-1 disease. "
11/01/1997 - "Oxandrolone for weight gain."
|1.||Growth Hormone (Somatotropin)
|2.||Human Growth Hormone (Saizen)
|9.||Megestrol Acetate (Borea)
|2.||Nutrition Therapy (Medical Nutrition Therapy)
|4.||Highly Active Antiretroviral Therapy (HAART)
|5.||Nutritional Support (Artificial Feeding)